HANALL BIOPHARMA

hanall-biopharma-logo

HanAll Biopharma is Worldโ€™s Best Bio Pharma for R&D of New Innovative Medicine Respectful Pharmaceutical Company to Contribute to Health of the World and to Lead Health Improvement of Mankind.

#SimilarOrganizations #People #Financial #Event #More

HANALL BIOPHARMA

Social Links:

Industry:
Biotechnology Fitness

Status:
Active

Contact:
306-81-05479

Email Addresses:
[email protected]

Technology used in webpage:
Apache Apache 2.4 Java EE OpenSSL GeoTrust SSL RapidSSL Unix OpenSSL 1.0.1 Apache Tomcat JK LG U Plus


Similar Organizations

arbutus-biopharma-logo

Arbutus Biopharma

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

bharat-serums-and-vaccines-logo

Bharat Serums and Vaccines

Bharat Serums and Vaccines develops biopharmaceutical products for patient health improvement.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

Current Employees Featured

not_available_image

Almira Chabi
Almira Chabi Chief Medical Officer and Chief Development Officer @ HanAll Biopharma
Chief Medical Officer and Chief Development Officer
2022-02-01

Investments List

Date Company Article Money raised
2022-04-11 Turn.bio HanAll Biopharma investment in Venture Round - Turn.bio N/A
2021-08-19 Alloplex Biotherapeutics HanAll Biopharma investment in Corporate Round - Alloplex Biotherapeutics 1000 K USD

More informations about "HanAll Biopharma"

ABOUT US - HANALL

HanAll Biopharma disclaims all express or implied warranties, including warranties of merchantability and fitness for a particular purpose. Neither HanAll Biopharma nor any parties involved in creating, producing, or delivering this โ€ฆSee details»

ABOUT US | HANALL

At HanAll Biopharma, our impact spans the globe with a dynamic and extensive network of research and development teams located in four different countries - Korea, the United States, Indonesia, and Japan. This global scale and reach โ€ฆSee details»

HANALL BIOPHARMA Co., Ltd. - Drug pipelines, Patents ... - Patsnap

May 1, 2023 About HanAll Biopharma HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with presence in Korea, the USA, Japan, and Indonesia with the โ€ฆSee details»

NEWS ROOM | HANALL

Both CEOs will collaborate in building the organization and business development to drive HanAllโ€™s next phase of growth in both domestic and global markets. ... About HanAll โ€ฆSee details»

HanAll Biopharma - Crunchbase Investor Profile

Contact Email [email protected] Phone Number 306-81-05479 HanAll Biopharma is Worldโ€™s Best Bio Pharma for R&D of New Innovative Medicine Respectful Pharmaceutical Company to Contribute to Health of the World and โ€ฆSee details»

HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next

Mar 29, 2023 Sean Jeong, who has served as a Co-CEO of HanAll Biopharma since March 2021, will continue to lead HanAllโ€™s R&D vision and strategy alongside Mr. Park, who will focus โ€ฆSee details»

HanAll BioPharma Company Profile - Office Locations ... - Craft

Oct 29, 2024 HanAll BioPharma has 5 employees across 4 locations and โ‚ฉ134.91 b in annual revenue in FY 2023. See insights on HanAll BioPharma including office locations, competitors, โ€ฆSee details»

HanAll Biopharma Co Ltd: Overview - GlobalData

HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, โ€ฆSee details»

HanAll Biopharma Co. Ltd. - BioCentury Company Profiles - BCIQ

Jul 15, 2024 HanAll Biopharma Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»

NEWS ROOM - HANALL

About HanAll Biopharma. HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with presence in Korea, the USA, Japan, and Indonesia with a mission of making โ€ฆSee details»

BQURA | Companies - Hanall Biopharma

Dec 6, 2024 HanAll Biopharma has established itself as a leader in innovative drug development, leveraging its global clinical development capabilities and antibody research โ€ฆSee details»

HanAll Biopharma Co - Company Profile - GlobalData

HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for the treatment of diseases related to digestive, endocrine, โ€ฆSee details»

HanAll Biopharma - Products, Competitors, Financials, Employees ...

HanAll Biopharma is a biopharmaceutical company focused on the research and development of innovative drugs. The company's main offerings include the development of treatments for โ€ฆSee details»

Hanall Biopharma - Overview, News & Similar companies

Oct 26, 2023 Who is Hanall Biopharma. HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company founded in 1973 with a mission of making meaningful โ€ฆSee details»

Turn Bio and HanAll to develop therapies for age-related conditions

May 29, 2024 HanAll Biopharma CEO Sean Jeong stated: โ€œTurn Bioโ€™s innovative approach to epigenetic reprogramming aligns closely with HanAllโ€™s mission to explore innovative medicines โ€ฆSee details»

HanAll Biopharma - Contacts, Employees, Board Members

HanAll Biopharma has 3 current employee profiles, including CEO & President Seung Kook Park. Contacts. Edit Contacts Section. Job Department. Protected Content. Operations. Director โ€ฆSee details»

NEWS ROOM | HANALL

Apr 30, 2024 About HanAll Biopharma. HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with a presence in Korea, the USA, Japan, and Indonesia with a โ€ฆSee details»

NEWS ROOM - HANALL

HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update 2023.07.28 l Sales recorded KRW 41.4 billion, a 58 percent increase from the same โ€ฆSee details»

HanAll Biopharma sees highest patent filings and grants during โ€ฆ

Feb 27, 2024 HanAll Biopharma saw the highest growth of 299% in patent filings in December and 99% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in โ€ฆSee details»

linkstock.net © 2022. All rights reserved